Adma Biologics, INC.
Doing business as Adma Biologics
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersRamsey, NJ
US patents7
SAM.gov UEIKJGJMLX7UYT1
CAGE code8NML8
Incorporated inDE
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
7 US patents granted 2015–2021, 1 of them in the five years to SEP 2025.
Pharmaceuticals 7
- Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infectionUS 11,084,870 · granted AUG 10, 2021
- Compositions and methods for the treatment of immunodeficiencyUS 10,683,343 · granted JUN 16, 2020
- Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infectionUS 10,259,865 · granted APR 16, 2019
- Compositions and methods for the treatment of immunodeficiencyUS 9,969,793 · granted MAY 15, 2018
- Compositions and methods for the treatment of immunodeficiencyUS 9,815,886 · granted NOV 14, 2017
Newest 5 shown · Granted to Adma Biologics, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Adma Biologics, INC. | Ramsey | NJ | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.
